Reilly Financial Advisors LLC trimmed its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 91.3% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 11,362 shares of the pharmacy operator’s stock after selling 119,034 shares during the period. Reilly Financial Advisors LLC’s holdings in Walgreens Boots Alliance were worth $621,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in WBA. The Manufacturers Life Insurance Company raised its holdings in shares of Walgreens Boots Alliance by 263.4% in the first quarter. The Manufacturers Life Insurance Company now owns 3,306,439 shares of the pharmacy operator’s stock valued at $209,198,000 after buying an additional 2,396,640 shares during the last quarter. Janus Henderson Group PLC raised its holdings in Walgreens Boots Alliance by 427.3% during the first quarter. Janus Henderson Group PLC now owns 1,732,966 shares of the pharmacy operator’s stock worth $109,642,000 after purchasing an additional 1,404,322 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec raised its holdings in Walgreens Boots Alliance by 11.4% during the first quarter. Caisse DE Depot ET Placement DU Quebec now owns 10,667,865 shares of the pharmacy operator’s stock worth $674,956,000 after purchasing an additional 1,093,610 shares in the last quarter. Geode Capital Management LLC raised its holdings in Walgreens Boots Alliance by 7.8% during the fourth quarter. Geode Capital Management LLC now owns 11,529,136 shares of the pharmacy operator’s stock worth $786,522,000 after purchasing an additional 834,241 shares in the last quarter. Finally, First Trust Advisors LP raised its holdings in Walgreens Boots Alliance by 76.5% during the first quarter. First Trust Advisors LP now owns 1,460,684 shares of the pharmacy operator’s stock worth $92,417,000 after purchasing an additional 632,919 shares in the last quarter. 62.19% of the stock is owned by institutional investors and hedge funds.
Several research analysts recently issued reports on the stock. Zacks Investment Research cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price target for the company. in a report on Monday, June 10th. Guggenheim assumed coverage on shares of Walgreens Boots Alliance in a report on Thursday, April 18th. They set a “neutral” rating and a $59.00 price target for the company. Morgan Stanley set a $61.00 price target on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Tuesday, May 14th. JPMorgan Chase & Co. cut their price target on shares of Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating for the company in a report on Friday, June 28th. Finally, ValuEngine raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, June 28th. Six equities research analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $63.82.
Walgreens Boots Alliance stock traded down $0.67 during mid-day trading on Friday, reaching $53.40. The company had a trading volume of 2,048,897 shares, compared to its average volume of 3,807,366. Walgreens Boots Alliance Inc has a 1 year low of $49.31 and a 1 year high of $86.31. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. The company has a market cap of $50.03 billion, a P/E ratio of 8.87, a P/E/G ratio of 1.39 and a beta of 0.82. The business’s 50-day simple moving average is $54.36.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.42 by $0.05. Walgreens Boots Alliance had a net margin of 3.53% and a return on equity of 22.08%. The company had revenue of $34.59 billion during the quarter, compared to analysts’ expectations of $34.52 billion. During the same period last year, the company posted $1.53 earnings per share. The firm’s quarterly revenue was up .7% compared to the same quarter last year. On average, analysts anticipate that Walgreens Boots Alliance Inc will post 5.98 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Shareholders of record on Tuesday, August 20th will be issued a $0.458 dividend. The ex-dividend date of this dividend is Monday, August 19th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. This represents a $1.83 dividend on an annualized basis and a yield of 3.43%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 29.24%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: When is a capital gain realized?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.